STERIS FY26 revenue $5.9B (+9%), adj EPS $10.17; FY27 guidance adj EPS $11.10-$11.30

STERIS plc

Full year revenue from continuing ops $5.9B (+9%), constant currency organic +7%; adjusted EPS $10.17 vs $9.22.
Q4 revenue $1.6B (+7%), adjusted EPS $2.83 vs $2.74; Healthcare rev $1.14B (+7%), AST $289.2M (+6%), Life Sci $162.9M (+9%).
FY26 operating cash flow $1.34B, free cash flow $982.9M (up from $787.2M).
FY27 guidance: revenue +7-8%, organic +6-7%, adj EPS $11.10-$11.30 (9-11% growth), capex ~$375M, FCF ~$850M.
Board authorized new $1B share repurchase program; $60M strategic investment for new sterility plant in Mentor, Ohio (operational late CY2027).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

STERIS plc reported the twelve months ended March 31, 2026 results: revenue $5.9 billion, net income $782.3 million or $7.93 per diluted share. Guidance raised.

Period: the twelve months ended March 31, 2026
Revenue: $5.9 billion
Net income: $782.3 million or $7.93 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

currency organic revenue growth from continuing operations grew 5% in the fourth quarter. Revenue from continuing operations for the full year fiscal 2026 increased 9% to $5.9 billion compared with $5.5 billion in fiscal 2025. Constant currency organic revenue growth from continuing operations grew 7% for fiscal 2026. “Fiscal 2026 was another record year,”

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

STERIS plc reported the three months ended March 31, 2026 results: revenue $1.6 billion, net income $220.3 million or $2.24 per diluted share.

Period: the three months ended March 31, 2026
Revenue: $1.6 billion
Net income: $220.3 million or $2.24 per diluted share
Result: reported results

Exact text from the filing

Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STERIS plc filing history →

Source: SEC EDGAR

accession 0001628280-26-033580

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.